J. Yamamoto

发表

Therapeutic Antibody Discovery in Infectious Diseases Using Single-Cell Analysis.

Veronique Etienne, C. Nguyen, A. Voigt, 2018, Advances in experimental medicine and biology.

Feline bone marrow transplantation: its use in FIV-infected cats.

F. Bova, B. Homer, L. Fox, 1998, Veterinary immunology and immunopathology.

HIV-1 Vaccine Trials: Evolving Concepts and Designs

J. Levy, A. D. De Groot, M. Murphey-Corb, 2012, The open AIDS journal.

Efficacy evaluation of prime–boost protocol: canarypoxvirus‐based feline immunodeficiency virus (FIV) vaccine and inactivated FIV‐infected cell vaccine against heterologous FIV challenge in cats

E. Paoletti, J. Tartaglia, A. Vitsky, 1998, AIDS.

Immunologic abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus

N. Pedersen, M. Cooper, J. Yamamoto, 1990, Journal of virology.

Conserved HIV Epitopes for an Effective HIV Vaccine

B. Sahay, C. Nguyen, J. Yamamoto, 2017, Journal of clinical & cellular immunology.

Advances in FIV vaccine technology.

E. Uhl, J. Yamamoto, J. Coleman, 2008, Veterinary immunology and immunopathology.

Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies: Efficacy and potential prophylactic mechanism(s) of prototype and commercial FIV vaccines

J. Yamamoto, J. Coleman, R. Pu, 2015 .

Superinfection of cats with feline immunodeficiency virus subtypes A and B.

J. Yamamoto, R. Pu, S. Okada, 1994, AIDS research and human retroviruses.

Phenotypic and functional characteristics of FIV infection in the bone marrow stroma.

T. Tanabe, J. Yamamoto, 2001, Virology.

HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection

E. Sato, J. Yamamoto, J. Coleman, 2005, AIDS.

The use of human hematopoietic growth factors (rhGM-CSF and rhEPO) as a supportive therapy for FIV-infected cats.

J. Darman, J. Yamamoto, M. Arai, 2000, Veterinary immunology and immunopathology.

Development of an on-chip detection of Zika virus and antibodies simultaneously using array of nanowells

M. Rathore, William Donelan, C. Nguyen, 2018, bioRxiv.

Molecular cloning of feline immunodeficiency virus.

R. Purcell, R. Olmsted, P. Johnson, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Interleukin 2 regulation of mitogen induction of immune interferon (IFN gamma) in spleen cells and thymocytes.

W. Farrar, H. Johnson, J. Yamamoto, 1982, Cellular immunology.

Pegylated feline granulocyte colony-stimulating factor increases neutrophil levels in cats.

H. Kondo, J. Abbott, S. Roff, 2014, Veterinary journal.

AIDS serology testing in low- and high-risk groups.

M B Gardner, S. Hinrichs, M. Gardner, 1985, JAMA.

Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission.

N. Pedersen, E. Ho, R. Nakamura, 1989, Journal of the American Veterinary Medical Association.

Molecular comparison of retroviruses associated with human and simian AIDS

N. Pedersen, P. Luciw, P. Marx, 1985, Hematological oncology.

Is AZT/3TC therapy effective against FIV infection or immunopathogenesis?

J. Yamamoto, M. Arai, D. D. Earl, 2002, Veterinary immunology and immunopathology.

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

N. Pedersen, E. Ho, M L Brown, 1987, Science.

Feline leukemia virus infection as a potentiating cofactor for the primary and secondary stages of experimentally induced feline immunodeficiency virus infection

N. Pedersen, P. Luciw, B. Rideout, 1990, Journal of virology.

Feline Immunodeficiency Virus Infection

N. Pedersen, Marian C. Horzinek, N C Pedersen, 2013, Canine and Feline Infectious Diseases.

Cellular immune responses to feline immunodeficiency virus (FIV) induced by dual-subtype FIV vaccine.

T. Tanabe, W. Hou, J. Yamamoto, 2004, Vaccine.

Development and evaluation of immunoassay for detection of antibodies to the feline T-lymphotropic lentivirus (feline immunodeficiency virus)

N. Pedersen, Q. Tonelli, J. Yamamoto, 1989, Journal of clinical microbiology.

Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.

N. Pedersen, E. Ho, L. Lowenstine, 1988, American journal of veterinary research.

Partial characterization of retroviruses from boid snakes with inclusion body disease.

J. Orós, A. Mergia, E. Jacobson, 2001, American journal of veterinary research.

Ultrastructural comparison of the retroviruses associated with human and simian acquired immunodeficiency syndromes.

P. Marx, M. Gardner, R. Munn, 1985, Laboratory investigation; a journal of technical methods and pathology.

FIV vaccine development and its importance to veterinary and human medicine: a review

E. Uhl, J. Yamamoto, R. Pu, 2002, Veterinary Immunology and Immunopathology.

Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus

M. Gardner, R. Olmsted, H. Johnson, 1993, Journal of Virology.

Feline immunodeficiency virus pathogenesis and development of a dual-subtype feline-immunodeficiency-virus vaccine.

E. Sato, J. Yamamoto, R. Pu, 2007, AIDS.

Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine

B. Sahay, J. Yamamoto, 2018, Viruses.

Dual-subtype FIV vaccine protects cats against in vivo swarms of both homologous and heterologous subtype FIV isolates

T. Tanabe, J. Yamamoto, J. Coleman, 2001, AIDS.

MHC-restricted protection of cats against FIV infection by adoptive transfer of immune cells from FIV-vaccinated donors.

J. Yamamoto, R. Pu, S. Okada, 1999, Cellular immunology.

Effect of dual-subtype vaccine against feline immunodeficiency virus infection

C. Aizawa, J. Yamamoto, T. Hohdatsu, 1997, Veterinary Microbiology.

Multi-subtype FIV vaccines

J. Yamamoto, 1997 .

Perspectives on FIV vaccine development.

J. Soos, J. Yamamoto, M. Tellier, 1997, Vaccine.

Development of FIV-specific cytolytic T-lymphocyte responses in cats upon immunisation with FIV vaccines.

J. Soos, J. Yamamoto, R. Pu, 1997, Veterinary microbiology.

Nucleotide sequence of feline immunodeficiency virus: classification of Japanese isolates into two subtypes which are distinct from non-Japanese subtypes

H. Hashimoto, S. Kakinuma, J. Yamamoto, 1995, Journal of virology.

Protection against homologous but not heterologous challenge induced by inactivated feline immunodeficiency virus vaccines

J. Neil, O. Jarrett, M. Hosie, 1995, Journal of virology.

FIV as a Model for AIDS Vaccination

Calvin M. Johnson, J. Yamamoto, B. Torres, 1994 .

Passive antibody protection of cats against feline immunodeficiency virus infection

M. Gardner, J. Yamamoto, R. Pu, 1993, Journal of virology.

Experimental vaccine protection against feline immunodeficiency virus.

M. Gardner, R. Munn, T. Okuda, 1991, AIDS research and human retroviruses.

Development of IL-2-independent feline lymphoid cell lines chronically infected with feline immunodeficiency virus: importance for diagnostic reagents and vaccines.

R. Munn, T. Okuda, J. Yamamoto, 1991, Intervirology.

Feline immunodeficiency virus as a model for AIDS vaccination.

J. Neil, O. Jarrett, J. Yamamoto, 1990, AIDS.

Bovine and Feline Immunodeficiency Viruses

J. Yamamoto, 2008 .

Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.

M. Gardner, J. Yamamoto, N. Pedersen, 1986, Journal of interferon research.

Feline immunodeficiency virus (FIV) vaccine efficacy and FIV neutralizing antibodies.

J. Yamamoto, J. Coleman, R. Pu, 2014, Vaccine.

Dual-subtype FIV vaccine (Fel-O-Vax® FIV) protection against a heterologous subtype B FIV isolate

E. Sato, T. Tanabe, J. Yamamoto, 2005, Journal of feline medicine and surgery.

Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau.

F. Bazer, T. Ott, C. Pontzer, 1997, Journal of immunology.

Cellular Regulation of Gamma Interferon Production: Lyt Phenotype of the Suppressor Cell

H. Johnson, J. Yamamoto, B. Torres, 1982, Infection and immunity.

A feline retrovirus induced T-lymphoblastoid cell-line that produces an atypical alpha type of interferon.

E. Ho, J. Yamamoto, N. Pedersen, 1986, Veterinary immunology and immunopathology.

Feline immunodeficiency virus model for designing HIV/AIDS vaccines.

J. Abbott, J. Yamamoto, J. Coleman, 2010, Current HIV research.

The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis

S. Roff, J. Yamamoto, E. Noon-Song, 2014, Front. Immunol..

Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects

J. Levy, M. Rathore, S. Roff, 2015, Human vaccines & immunotherapeutics.

Evolutionarily conserved T-cell epitopes on FIV for designing an HIV/AIDS vaccine.

J. Abbott, J. Yamamoto, J. Coleman, 2011, Veterinary immunology and immunopathology.

Feline Coronavirus Infection of Domestic Cats Causes Development of Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain

J. Garrett Morris, B. Sahay, S. Tompkins, 2022, bioRxiv.

Feline immunodeficiency virus is a lentivirus associated with an AIDS‐like disease in cats

N. Pedersen, P. Luciw, L. Lowenstine, 1989, AIDS.

Utilization of Feline ELISpot to Evaluate the Immunogenicity of a T Cell-Based FIV MAP Vaccine.

B. Sahay, J. Yamamoto, Andrew C. McAvoy, 2018, Methods in molecular biology.

Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses

B. Sahay, M. Dark, M. Rathore, 2019, Viruses.

An initial examination of the potential role of T-cell immunity in protection against feline immunodeficiency virus (FIV) infection.

S. Roff, J. Yamamoto, J. Coleman, 2016, Vaccine.

Mechanism of HIV pathogenesis: role of superantigens in disease.

P. Subramaniam, H. Johnson, T. Tanabe, 1998, Alcoholism, clinical and experimental research.

Evolutionarily Conserved Epitopes on Human Immunodeficiency Virus Type 1 (HIV-1) and Feline Immunodeficiency Virus Reverse Transcriptases Detected by HIV-1-Infected Subjects

J. Levy, J. Sleasman, M. Rathore, 2013, Journal of Virology.

Both Feline Coronavirus Serotypes 1 and 2 Infected Domestic Cats Develop Cross-Reactive Antibodies to SARS-CoV-2 Receptor Binding Domain: Its Implication to Pan-CoV Vaccine Development

J. Garrett Morris, B. Sahay, S. Tompkins, 2023, Viruses.

Utilization of feline ELISPOT for mapping vaccine epitopes.

J. Abbott, J. Yamamoto, J. Coleman, 2012, Methods in molecular biology.

Inhibition of human immunodeficiency virus type 1 replication by human interferons alpha, beta and gamma.

J. Yamamoto, M. Kruzel, J. Georgiades, 1993, Archivum immunologiae et therapiae experimentalis.

Workshop Summary: Lessons from the Cat: Feline Immunodeficiency Virus as a Tool to Develop Intervention Strategies against Human Immunodeficiency Virus Type 1

M. Malim, J. Hoxie, W. Tompkins, 1998 .

Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1.

N. Pedersen, M. Malim, J. Hoxie, 1998, AIDS research and human retroviruses.

Vaccine protection against feline immunodeficiency virus: setting the challenge.

J. Yamamoto, R. Zwijnenberg, 2007, Australian veterinary journal.

Feline immunodeficiency virus lacks sensitivity to the antiviral activity of feline IFN-gamma.

T. Tanabe, J. Yamamoto, 2001, Journal of Interferon and Cytokine Research.

Feline Immunodeficiency Virus Lacks Sensitivity to the Antiviral Activity of Feline IFN-γ

T. Tanabe, J. Yamamoto, 2001 .

Feline immunodeficiency virus infection.

N. Pedersen, J. Yamamoto, T. Ishida, 1989, Veterinary immunology and immunopathology.